Systemic immunity influences hearing preservation in cochlear implantation

Area of Science:

• Otolaryngology
• Immunology
• Neuroscience

Background:

• Cochlear implantation aims to restore hearing in sensorineural hearing loss.
• The influence of systemic immune responses on cochlear implant efficacy is not fully understood.
• Pre-existing immune activation may alter the cochlear environment and surgical outcomes.

Purpose of the Study:

• To investigate the impact of a systemic immune response on hearing thresholds and cochlear tissue following implantation.
• To evaluate the protective effect of local dexamethasone treatment in immune-activated guinea pigs undergoing cochlear implantation.

Main Methods:

• Guinea pigs were systemically immunized with Keyhole Limpet Hemocyanin (KLH) 3 weeks prior to cochlear implantation.
• Auditory brainstem response thresholds were measured pre-implantation and at 1 and 4 weeks post-implantation.
• Local dexamethasone or saline was applied to the round window before electrode insertion; cochlear histology assessed tissue response.

Main Results:

• KLH priming alone did not affect pre-implantation hearing thresholds.
• Implantation in KLH-primed animals elevated thresholds across a broader frequency range (2-32 kHz) compared to controls (4-32 kHz).
• Dexamethasone treatment in primed animals significantly reduced threshold shifts at 2 and 8 kHz, and decreased lymphocyte infiltration.

Conclusions:

• Systemic immune activation at the time of cochlear implantation exacerbates hearing threshold elevation.
• Local dexamethasone provides partial protection against this immune-mediated hearing loss, though less effectively than in non-primed animals.
• These findings underscore the importance of considering systemic immune status in cochlear implantation outcomes and treatment strategies.